$Novo Nordisk AS(NVO.US)

Let me share my thoughts: In the future, there will only be more and more patients with diabetes and obesity, so there is still market potential.

As a century-old Danish pharmaceutical company, Novo Nordisk has now fallen to this point. I can accept the dividend yield + potential return. I'm entering with a small position, picking up some blood-stained chips. A 10x P/E ratio is almost at rock bottom. If you invest, buy the sector you believe in and excellent companies, hold for the long term until the fundamentals deteriorate beyond repair, and I will exit immediately. At least for now, I still have confidence in NVO.